Cargando…
6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes
Monocytes are subdivided into three subsets, which have different phenotypic and functional characteristics and different roles in inflammation and malignancy. When in man CD14 and CD16 monoclonal antibodies are used to define these subsets, then the distinction of non-classical CD14low and intermed...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753898/ https://www.ncbi.nlm.nih.gov/pubmed/31572354 http://dx.doi.org/10.3389/fimmu.2019.02052 |
_version_ | 1783452983407673344 |
---|---|
author | Hofer, Thomas P. van de Loosdrecht, Arjan A. Stahl-Hennig, Christiane Cassatella, Marco A. Ziegler-Heitbrock, Loems |
author_facet | Hofer, Thomas P. van de Loosdrecht, Arjan A. Stahl-Hennig, Christiane Cassatella, Marco A. Ziegler-Heitbrock, Loems |
author_sort | Hofer, Thomas P. |
collection | PubMed |
description | Monocytes are subdivided into three subsets, which have different phenotypic and functional characteristics and different roles in inflammation and malignancy. When in man CD14 and CD16 monoclonal antibodies are used to define these subsets, then the distinction of non-classical CD14low and intermediate CD14high monocytes requires setting a gate in what is a gradually changing level of CD14 expression. In the search for an additional marker to better dissect the two subsets we have explored the marker 6-sulfo LacNAc (slan). Slan is a carbohydrate residue originally described to be expressed on the cell surface of a type of dendritic cell in human blood. We elaborate herein that the features of slan+ cells are congruent with the features of CD16+ non-classical monocytes and that slan is a candidate marker for definition of non-classical monocytes. The use of this marker may help in studying the role of non-classical monocytes in health and in diagnosis and monitoring of disease. |
format | Online Article Text |
id | pubmed-6753898 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67538982019-09-30 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes Hofer, Thomas P. van de Loosdrecht, Arjan A. Stahl-Hennig, Christiane Cassatella, Marco A. Ziegler-Heitbrock, Loems Front Immunol Immunology Monocytes are subdivided into three subsets, which have different phenotypic and functional characteristics and different roles in inflammation and malignancy. When in man CD14 and CD16 monoclonal antibodies are used to define these subsets, then the distinction of non-classical CD14low and intermediate CD14high monocytes requires setting a gate in what is a gradually changing level of CD14 expression. In the search for an additional marker to better dissect the two subsets we have explored the marker 6-sulfo LacNAc (slan). Slan is a carbohydrate residue originally described to be expressed on the cell surface of a type of dendritic cell in human blood. We elaborate herein that the features of slan+ cells are congruent with the features of CD16+ non-classical monocytes and that slan is a candidate marker for definition of non-classical monocytes. The use of this marker may help in studying the role of non-classical monocytes in health and in diagnosis and monitoring of disease. Frontiers Media S.A. 2019-09-13 /pmc/articles/PMC6753898/ /pubmed/31572354 http://dx.doi.org/10.3389/fimmu.2019.02052 Text en Copyright © 2019 Hofer, van de Loosdrecht, Stahl-Hennig, Cassatella and Ziegler-Heitbrock. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Hofer, Thomas P. van de Loosdrecht, Arjan A. Stahl-Hennig, Christiane Cassatella, Marco A. Ziegler-Heitbrock, Loems 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes |
title | 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes |
title_full | 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes |
title_fullStr | 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes |
title_full_unstemmed | 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes |
title_short | 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes |
title_sort | 6-sulfo lacnac (slan) as a marker for non-classical monocytes |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753898/ https://www.ncbi.nlm.nih.gov/pubmed/31572354 http://dx.doi.org/10.3389/fimmu.2019.02052 |
work_keys_str_mv | AT hoferthomasp 6sulfolacnacslanasamarkerfornonclassicalmonocytes AT vandeloosdrechtarjana 6sulfolacnacslanasamarkerfornonclassicalmonocytes AT stahlhennigchristiane 6sulfolacnacslanasamarkerfornonclassicalmonocytes AT cassatellamarcoa 6sulfolacnacslanasamarkerfornonclassicalmonocytes AT zieglerheitbrockloems 6sulfolacnacslanasamarkerfornonclassicalmonocytes |